Medical News

DPP4i better than SU for T2DM Patients with Comorbidities

Metformin in combination with dipeptidyl peptidase-4 inhibitors (MET+ DPP4i) is a more favorable combination than MET + sulfonylureas (SU) for...

20 Mar, 2018

Email this page
Obese Wife: A Risk Factor for Type-2 Diabetes in Men?

A recent study demonstrated a gender-specific impact of spousal obesity on the risk of type-2 diabetes mellitus (T2DM), particularly in men. ...

14 Mar, 2018

Email this page
Obesity from Youth to Mid-Life, Linked to High Risk of Incident Diabetes

People, who remain obese from youth to mid-life bear the greatest burden of incident diabetes, stated a recent study with a 10-year follow-up. The...

12 Mar, 2018

Email this page
Early-Onset Type-2 Diabetes more Pathogenic than Late Onset Disease

People who develop type-2 diabetes mellitus (T2DM) at a younger age are more frequently obese, have more adverse lipid profile along with higher...

09 Mar, 2018

Email this page

Key Trials

CARDIA Study: Lactation Duration Inversely Associated with Diabetes Progression in Women across the Childbearing Years

The CARDIA study with a 30-year follow-up demonstrated an inverse association between lactation duration and progression of diabetes in women.

Benefits of Initial Combination Therapy of Vildagliptin/Metformin in Asian T2DM Patients

Combination therapy of vildagliptin/metformin demonstrated consistent HbA1c reduction across wide spectrum of drug naïve Asian T2DM patients.

Sacubitril/Valsartan Enhances Glycemic Control in Heart Failure Patients with Diabetes

As per the study sacubitril/valsartan causes greater reduction in HbA1c vs. enalapril and cuts new insulin initiation in diabetes patients with...

Azilsartan is Superior to Olmesartan in Hypertensives with Type 2 Diabetes/ Prediabetes

This study shows that azilsartan can be the preferred ARB in hypertensives with prediabetes or type 2 diabetes

Patient Education

Know More about Diabetes

Diabetes implies high blood sugar levels in blood. Find out more about the cause, risk factors and complications associated with this disease.


The ancient science of yoga provides various health benefits to an individual. Know more about the ‘asanas’ that are beneficial for diabetes...


Stretching improves our flexibility and physical performance. Understand the correct stretching techniques to reap maximum health benefits from them...


Walking is a simple exercise with numerous health benefits for all.  A simple, step-wise walking program is important for effective diabetes control...

Our Publications

Mind Matters (Issue 3) - Role of Escitalopram in the Treatment of Comorbid Depression and Diabetes

The presence of depression in patients with diabetes mellitus is of vast importance, as it is usually associated with poor disease control, adverse...

Diabetes Management Series: Cholesterol

Most relevant information on management of dyslipidemia, a common comorbidity observed in diabetes patients, has been summarised in this document.

Drug Therapy for Management of Hyperglycaemia

Brief information on the treatment strategy and selection of oral antihyperglycemic agents in type 2 diabetes is summarised in this document.

Diabetes Management Series: Hypertension

Hypertension elevates the risk of micro-and macro-vascular complications in diabetes. Here is a summary on the BP treatment goals in diabetes...

Slide Library

Clinical Practice Recommendations: ADA 2014

This slide set summarizes the key 2014 clinical practice recommendations of the American Diabetes Association (ADA) on the screening, diagnosis and...

Email this page
Diabetic Dyslipidemia

Dyslipidemia is one of the key risk factors for cardiovascular disease (CVD) in diabetes mellitus. This slide set provides information on the...

Email this page
Treating Hypertension in Diabetics : Optimal Selection of Antihypertensive Therapy

Hypertension affects 20%-60% of diabetics. It substantially increases the risk of macrovascular and microvascular complications in diabetes. This...

Email this page
The ‘Four Facets’ of Glucose Control: Focus on Voglibose and Metformin Combination

This slide set addresses the need to progress from the glucose triad to the glucose pyramid for achieving steady glucose control. The effectiveness...

Email this page


Which is your preferred DPP4 inhibitor for your type 2 diabetes patients with ESRD?
13% (1 vote)
38% (3 votes)
38% (3 votes)
No specific choice
13% (1 vote)
Don’t prefer a DPP4 inhibitor
0% (0 votes)
Total votes: 8